Leuprolide acetate/Norethindrone Acetate

醋酸亮丙瑞林/醋炔诺酮

Report date: 2024/06/28 17:31:33

Base Information

Drug NameLeuprolide acetate/Norethindrone Acetate
Drug Alias NameLeuprolide acetate and Norethindrone Acetate醋炔诺酮/醋酸亮丙瑞林Norethindrone Acetate/Leuprolide acetateLeuprorelin acetate/Norethindrone AcetateLupaneta Pack
ClassificationSmall molecules
Mechanisms of ActionProgesterone receptor agonistsGonadotropin-releasing hormone agonists
TargetsGonadotropin-releasing hormoneProgesterone receptor
Therapy Area/IndicationsEndometriosisProstatic Neoplasms
Global Approved IndicationsEndometriosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/12/14
Country/TerritoryUnited States
CombinationsYes Leuprorelin acetateNorethindrone Acetate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesInvagen Pharmaceuticals, Inc
Inactive CompaniesAbbvie Endocrine Inc
Active IndicationsProstatic Neoplasms
Inactive IndicationsEndometriosis

Other Information

ATC CodeG
Related LinksN/A